Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, Smithson WA, Robison LL.

J Clin Oncol. 2001 Jul 1;19(13):3163-72.

PMID:
11432882
2.

Cause of mortality in 5-year survivors of childhood cancer.

Mertens AC.

Pediatr Blood Cancer. 2007 Jun 15;48(7):723-6. Review.

PMID:
17226844
3.

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC.

J Clin Oncol. 2009 May 10;27(14):2328-38. doi: 10.1200/JCO.2008.21.1425. Epub 2009 Mar 30. Review.

4.

Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD.

J Clin Oncol. 2009 May 10;27(14):2356-62. doi: 10.1200/JCO.2008.21.1920. Epub 2009 Mar 2. Review.

5.

Long-term survivors of childhood cancers: what knowledge have we gained?

Hawkins MM.

Nat Clin Pract Oncol. 2004 Nov;1(1):26-31. Review.

PMID:
16264796
6.

Physical performance limitations in the Childhood Cancer Survivor Study cohort.

Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, Whitton J, Robison LL, Gurney JG.

J Clin Oncol. 2009 May 10;27(14):2382-9. doi: 10.1200/JCO.2008.21.1482. Epub 2009 Mar 30. Review.

7.

Mortality Among Children And Young People Who Survive Cancer In Northern Ireland.

Donnelly DW, Gavin AT.

Ulster Med J. 2016 Sep;85(3):158-163. Review.

8.

Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts.

Morgan E, Cardwell CR, Black CJ, McCance DR, Patterson CC.

Acta Diabetol. 2015 Aug;52(4):801-7. doi: 10.1007/s00592-014-0702-z. Epub 2015 Jan 15. Review.

PMID:
25585594
9.

Pulmonary outcomes in survivors of childhood cancer: a systematic review.

Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK.

Chest. 2011 Oct;140(4):881-901. doi: 10.1378/chest.10-2133. Epub 2011 Mar 17. Review.

10.

Late endocrine effects of cancer and cancer therapies in survivors of childhood malignancies.

Marques P, Van Huellen H, Fitzpatrick A, Druce M.

Minerva Endocrinol. 2016 Mar;41(1):78-104. Epub 2015 Sep 10. Review.

PMID:
26365476
11.

The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK.

J Clin Oncol. 2009 May 10;27(14):2308-18. doi: 10.1200/JCO.2009.22.3339. Epub 2009 Apr 13. Review.

12.

Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Robison LL, Hudson MM.

Nat Rev Cancer. 2014 Jan;14(1):61-70. doi: 10.1038/nrc3634. Epub 2013 Dec 5. Review.

PMID:
24304873
13.

Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: A systematic review and meta-analysis.

Scholz-Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, Merzenich H, Hennewig U.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26428. Epub 2017 Feb 16. Review.

PMID:
28205419
14.

Risk-based health monitoring of childhood cancer survivors: a report from the Children's Oncology Group.

Nunez SB, Mulrooney DA, Laverdiere C, Hudson MM.

Curr Oncol Rep. 2007 Nov;9(6):440-52. Review.

PMID:
17991351
15.

Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Tonorezos ES, Hudson MM, Edgar AB, Kremer LC, Sklar CA, Wallace WH, Oeffinger KC.

Lancet Diabetes Endocrinol. 2015 Jul;3(7):545-55. doi: 10.1016/S2213-8587(15)00038-8. Epub 2015 Apr 12. Review.

16.

A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Gawade PL, Hudson MM, Kaste SC, Neglia JP, Wasilewski-Masker K, Constine LS, Robison LL, Ness KK.

Curr Pediatr Rev. 2014;10(4):249-62. Review.

17.

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.

Bhatia S.

Cancer. 2015 Mar 1;121(5):648-63. doi: 10.1002/cncr.29096. Epub 2014 Oct 29. Review.

18.

Long-Term and Latent Side Effects of Specific Cancer Types.

Gegechkori N, Haines L, Lin JJ.

Med Clin North Am. 2017 Nov;101(6):1053-1073. doi: 10.1016/j.mcna.2017.06.003. Epub 2017 Aug 2. Review.

PMID:
28992854
19.

Development of Metabolic Syndrome Associated to Cancer Therapy: Review.

Casco S, Soto-Vega E.

Horm Cancer. 2016 Dec;7(5-6):289-295. Epub 2016 Oct 4. Review.

PMID:
27704369
20.

Meningiomas occurring during long-term survival after treatment for childhood cancer.

Sugden E, Taylor A, Pretorius P, Kennedy C, Bhangoo R.

JRSM Open. 2014 Mar 12;5(4):2054270414524567. doi: 10.1177/2054270414524567. eCollection 2014 Apr. Review.

Supplemental Content

Support Center